Skip to main content
    P

    Phio Pharmaceuticals Corp (PHIO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.72
    -0.03 (-4.65%)

    Market Cap: $8.99M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Phio Pharmaceuticals Corp (PHIO) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Phio Pharmaceuticals (PHIO) has a market cap of $8.99M. Its share count is up 142.29% from a year earlier. It holds $13.00M more cash than debt, 144.56% of its market cap.

    Total Valuation

    Market Cap$8.99M
    Latest price (Nov 17, 2026)$0.72

    Key Dates

    The next earnings report is expected on Mar 3, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 3, 2027 (expected)
    Last Earnings DateNov 5, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count held steady in the quarter ended Jun 30, 2026.

    Shares Outstanding11.62M
    Shares Change (YoY)+142.29%
    Shares Change (QoQ)0.00%

    Price Statistics

    The stock is down 44.83% over 52 weeks and trades 22.58% below its 50-day average.

    Beta (1Y)1.12
    52-Week Change-44.83%
    1-Month Change-17.46%
    3-Month Change-37.63%
    6-Month Change-32.34%
    5-Year Change-99.53%
    10-Year Change-100.00%
    Total Return (1Y)-44.83%
    Total Return (3Y CAGR)-57.24%
    Total Return (5Y CAGR)-65.58%
    Max Drawdown (1Y)-56.53%
    Max Drawdown (3Y)-94.99%
    Sharpe Ratio (1Y)-0.76
    Correlation with SPY (1Y)0.21
    50-Day Average$0.93
    200-Day Average$1.07
    52-Week Range$0.72 to $1.88
    RSI (14 Days)27.3
    Average Volume (20 Days)63.68K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 8.39x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio8.39x
    Quick Ratio8.39x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -102.40% and return on assets is -90.19% over the last 12 months.

    Return on Equity (ROE)-102.40%
    Return on Assets (ROA)-90.19%
    ROA (5Y Average)-84.62%
    ROIC (5Y Average)-36.15%

    Scores

    PHIO has a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $0 over the last 12 months is down 100.00% from the 12 months before.

    Revenue$0
    Revenue Growth (YoY)-100.00%
    Gross Profit-$1.00K
    Operating Income-$13.47M
    Pretax Income-$12.93M
    Net Income-$12.90M
    Reported EPS (TTM)-$1.21

    Trailing 12 months through Jun 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 88.05% of the $14.31M in total assets.

    Cash and Equivalents$13.00M
    Total Debt$0
    Net Cash$13.00M
    Net Cash Per Share$1.12
    Working Capital$12.59M
    Shareholder Equity$12.60M
    Book Value Per Share$1.08
    Total Assets$14.31M
    Total Liabilities$1.71M

    Balance sheet as of Jun 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$12.20M
    FCF Per Share-$1.05
    Depreciation and Amortization$5.00K

    Trailing 12 months through Jun 30, 2026.

    Full cash flow statement

    Dividends and Yields

    PHIO does not pay a dividend.

    Buyback Yield-137.09%
    Shareholder Yield-137.09%

    Stock Splits

    The last split was a 1-for-9 reverse split on Jul 5, 2024.

    Last Split DateJul 5, 2024
    Split TypeReverse split
    Split Ratio1:9

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About PHIO

    What is PHIO's market cap?

    Phio Pharmaceuticals has a market cap of $8.99M.

    How many shares of PHIO are outstanding?

    Phio Pharmaceuticals has 11.62M shares outstanding. The count is up 142.29% from a year earlier.

    Does PHIO pay a dividend?

    No. Phio Pharmaceuticals does not pay a dividend.

    How much debt does PHIO have?

    Phio Pharmaceuticals has $0 of total debt and $13.00M of cash and equivalents, a net cash position of $13.00M.